| Characteristic . | . |
|---|---|
| Age (years) | 62 ± 15 |
| Gender, n (%) | Male 55 (77) |
| Female 16 (23) | |
| Ejection fraction (%) | 38 ± 15 |
| Comorbidities | |
| IHD, n (%) | 29 (41) |
| Cardiac surgery, n (%) | 19 (27) |
| Diabetes, n (%) | 5 (7) |
| Hypertension, n (%) | 16 (23) |
| PVD, n (%) | 3 (4) |
| Stroke, n (%) | 5 (7) |
| COPD, n (%) | 14 (20) |
| CKD, n (%) | 12 (17) |
| Characteristic . | . |
|---|---|
| Age (years) | 62 ± 15 |
| Gender, n (%) | Male 55 (77) |
| Female 16 (23) | |
| Ejection fraction (%) | 38 ± 15 |
| Comorbidities | |
| IHD, n (%) | 29 (41) |
| Cardiac surgery, n (%) | 19 (27) |
| Diabetes, n (%) | 5 (7) |
| Hypertension, n (%) | 16 (23) |
| PVD, n (%) | 3 (4) |
| Stroke, n (%) | 5 (7) |
| COPD, n (%) | 14 (20) |
| CKD, n (%) | 12 (17) |
IHD, ischaemic heart disease; PVD, peripheral vascular disease; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease.
| Characteristic . | . |
|---|---|
| Age (years) | 62 ± 15 |
| Gender, n (%) | Male 55 (77) |
| Female 16 (23) | |
| Ejection fraction (%) | 38 ± 15 |
| Comorbidities | |
| IHD, n (%) | 29 (41) |
| Cardiac surgery, n (%) | 19 (27) |
| Diabetes, n (%) | 5 (7) |
| Hypertension, n (%) | 16 (23) |
| PVD, n (%) | 3 (4) |
| Stroke, n (%) | 5 (7) |
| COPD, n (%) | 14 (20) |
| CKD, n (%) | 12 (17) |
| Characteristic . | . |
|---|---|
| Age (years) | 62 ± 15 |
| Gender, n (%) | Male 55 (77) |
| Female 16 (23) | |
| Ejection fraction (%) | 38 ± 15 |
| Comorbidities | |
| IHD, n (%) | 29 (41) |
| Cardiac surgery, n (%) | 19 (27) |
| Diabetes, n (%) | 5 (7) |
| Hypertension, n (%) | 16 (23) |
| PVD, n (%) | 3 (4) |
| Stroke, n (%) | 5 (7) |
| COPD, n (%) | 14 (20) |
| CKD, n (%) | 12 (17) |
IHD, ischaemic heart disease; PVD, peripheral vascular disease; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
